AIMS: To evaluate the effects of transient hypoglycaemia on the first day of life in 75 healthy term large for gestational age (LGA) infants, born to non-diabetic mothers, on their neurodevelopmental outcome at the age of 4 years. METHODS: Screening for hypoglycaemia was performed 1, 3, and 5 hours after birth, and continued if blood glucose levels were low. Treatment with intravenous glucose for hypoglycaemia was started if hypoglycaemia was severe or symptomatic. Patients' development and behaviour was examined at the age of 4 years by the Denver Developmental Scale, a non-verbal intelligence test, and the Child Behaviour Check List. RESULTS: There were no significant differences between children with neonatal normoglycaemia (n = 15) and hypoglycaemia (plasma glucose <2.2 mmol/l 1 hour after birth, or <2.5 mmol/l subsequently; n = 60) in Denver developmental scale scores and child behaviour checklist scores. Although total IQ did not differ between hypoglycaemic and normoglycaemic children, one subscale (reasoning) did (mean difference 9.3, 95% CI 1.3 to 17.2). The correlation between reasoning IQ and neonatal blood glucose levels was weak and not statistically significant. When other definitions for hypoglycaemia were applied, the difference in reasoning IQ was not found. There were no differences in any of the test scores between hypoglycaemic children who had and who had not been treated with intravenous glucose. CONCLUSION: Transient mild hypoglycaemia in healthy, term LGA newborns does not appear to be harmful to psychomotor development at the age of 4 years.
AIMS: To evaluate the effects of transient hypoglycaemia on the first day of life in 75 healthy term large for gestational age (LGA) infants, born to non-diabetic mothers, on their neurodevelopmental outcome at the age of 4 years. METHODS: Screening for hypoglycaemia was performed 1, 3, and 5 hours after birth, and continued if blood glucose levels were low. Treatment with intravenous glucose for hypoglycaemia was started if hypoglycaemia was severe or symptomatic. Patients' development and behaviour was examined at the age of 4 years by the Denver Developmental Scale, a non-verbal intelligence test, and the Child Behaviour Check List. RESULTS: There were no significant differences between children with neonatal normoglycaemia (n = 15) and hypoglycaemia (plasma glucose <2.2 mmol/l 1 hour after birth, or <2.5 mmol/l subsequently; n = 60) in Denver developmental scale scores and child behaviour checklist scores. Although total IQ did not differ between hypoglycaemic and normoglycaemic children, one subscale (reasoning) did (mean difference 9.3, 95% CI 1.3 to 17.2). The correlation between reasoning IQ and neonatal blood glucose levels was weak and not statistically significant. When other definitions for hypoglycaemia were applied, the difference in reasoning IQ was not found. There were no differences in any of the test scores between hypoglycaemic children who had and who had not been treated with intravenous glucose. CONCLUSION: Transient mild hypoglycaemia in healthy, term LGA newborns does not appear to be harmful to psychomotor development at the age of 4 years.
Authors: Ute M Schaefer-Graf; Rainer Rossi; Christoph Bührer; Gerda Siebert; Siri L Kjos; Joachim W Dudenhausen; Klaus Vetter Journal: Am J Obstet Gynecol Date: 2002-10 Impact factor: 8.661
Authors: Jennifer Croke; Meagan Sullivan; Anne Ryan-Drover; Ed Randell; Wayne Andrews; Khalid Aziz Journal: Paediatr Child Health Date: 2009-04 Impact factor: 2.253
Authors: Rajesh Shah; Darren W T Dai; Jane M Alsweiler; Gavin T L Brown; J Geoffrey Chase; Gregory D Gamble; Deborah L Harris; Peter Keegan; Samson Nivins; Trecia A Wouldes; Benjamin Thompson; Jason Turuwhenua; Jane E Harding; Christopher J D McKinlay Journal: JAMA Date: 2022-03-22 Impact factor: 157.335
Authors: Rachel H Goode; Mallikarjuna Rettiganti; Jingyun Li; Robert E Lyle; Leanne Whiteside-Mansell; Kathleen W Barrett; Patrick H Casey Journal: Pediatrics Date: 2016-11-04 Impact factor: 7.124
Authors: Montasser Nadeem; Deirdre M Murray; Geraldine B Boylan; Eugene M Dempsey; Cornelius A Ryan Journal: BMC Pediatr Date: 2011-02-04 Impact factor: 2.125